Profilo
David Wehner is the founder of Venneos GmbH, a company founded in 2014, where he holds the title of Managing Director.
Currently, he is working as a Senior Investment Manager at SHS Gesellschaft für Beteiligungsmanagement mbH since 2019.
Posizioni attive di David Wehner
| Società | Posizione | Inizio |
|---|---|---|
Venneos GmbH
 Venneos GmbH BiotechnologyHealth Technology Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany. | Amministratore Delegato | 01/01/2014 |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Investitore di Private Equity | 01/09/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
SHS Gesellschaft für Beteiligungsmanagement mbH
SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Finance |
Venneos GmbH
Venneos GmbH BiotechnologyHealth Technology Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany. | Health Technology |
- Borsa valori
- Insiders
- David Wehner
